Global Antisense and RNAi Therapeutics Market Research Report 2021 - Impact of COVID-19 on the Market

Publisher Name :
Date: 03-Feb-2022
No. of pages: 97

The Antisense and RNAi Therapeutics market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Antisense and RNAi Therapeutics market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Antisense and RNAi Therapeutics Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Antisense and RNAi Therapeutics market are:

Alnylam Pharmaceuticals

GSK

Sanofi-Genzyme

Marina Biosciences

Benitec Biopharma

Most important types of Antisense and RNAi Therapeutics products covered in this report are:

RNA Interference

Antisense RNA

Most widely used downstream fields of Antisense and RNAi Therapeutics market covered in this report are:

Oncology

Cardiovascular Diseases (CVDs)

Respiratory Disorders

Renal Diseases

Neurodegenerative Disorders

Genetic Disorders

Infectious Diseases

Other

Major Regions or countries covered in this report:

North America

Europe

China

Japan

Middle East and Africa

South America

India

South Korea

Southeast Asia

Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:

Historical Years: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2021-2026

Global Antisense and RNAi Therapeutics Market Research Report 2021 - Impact of COVID-19 on the Market

Table of Content

1 Antisense and RNAi Therapeutics Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Antisense and RNAi Therapeutics
1.3 Antisense and RNAi Therapeutics Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Antisense and RNAi Therapeutics Revenue and Growth Rate from 2016-2026
1.4 Market Segmentation
1.4.1 Types of Antisense and RNAi Therapeutics
1.4.2 Applications of Antisense and RNAi Therapeutics
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Antisense and RNAi Therapeutics Industry Trends
1.5.2 Antisense and RNAi Therapeutics Drivers
1.5.3 Antisense and RNAi Therapeutics Market Challenges
1.5.4 Antisense and RNAi Therapeutics Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Antisense and RNAi Therapeutics Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Antisense and RNAi Therapeutics Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Antisense and RNAi Therapeutics Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Antisense and RNAi Therapeutics
2.2.1 Major Players Manufacturing Base of Antisense and RNAi Therapeutics in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Antisense and RNAi Therapeutics Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Antisense and RNAi Therapeutics
2.3.3 Labor Cost of Antisense and RNAi Therapeutics
2.4 Market Channel Analysis of Antisense and RNAi Therapeutics
2.5 Major Down Stream Customers by Application

3 Global Antisense and RNAi Therapeutics Market, by Type
3.1 Global Antisense and RNAi Therapeutics Revenue and Market Share by Type (2016-2021)
3.2 Global Antisense and RNAi Therapeutics Production and Market Share by Type (2016-2021)
3.3 Global Antisense and RNAi Therapeutics Revenue and Growth Rate by Type (2016-2021)
3.3.1 Global Antisense and RNAi Therapeutics Revenue and Growth Rate of RNA Interference
3.3.2 Global Antisense and RNAi Therapeutics Revenue and Growth Rate of Antisense RNA
3.4 Global Antisense and RNAi Therapeutics Price Analysis by Type (2016-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Antisense and RNAi Therapeutics Market, by Application
4.1 Downstream Market Overview
4.2 Global Antisense and RNAi Therapeutics Consumption and Market Share by Application (2016-2021)
4.3 Global Antisense and RNAi Therapeutics Consumption and Growth Rate by Application (2016-2021)
4.3.1 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Oncology (2016-2021)
4.3.2 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Cardiovascular Diseases (CVDs) (2016-2021)
4.3.3 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Respiratory Disorders (2016-2021)
4.3.4 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Renal Diseases (2016-2021)
4.3.5 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Neurodegenerative Disorders (2016-2021)
4.3.6 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Genetic Disorders (2016-2021)
4.3.7 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Infectious Diseases (2016-2021)
4.3.8 Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Other (2016-2021)

5 Global Antisense and RNAi Therapeutics Consumption, Revenue ($) by Region (2016-2021)
5.1 Global Antisense and RNAi Therapeutics Revenue and Market Share by Region (2016-2021)
5.2 Global Antisense and RNAi Therapeutics Consumption and Market Share by Region (2016-2021)
5.3 Global Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.4 North America Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.4.1 North America Antisense and RNAi Therapeutics Market Under COVID-19
5.4.2 North America Antisense and RNAi Therapeutics SWOT Analysis
5.5 Europe Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.5.1 Europe Antisense and RNAi Therapeutics Market Under COVID-19
5.5.2 Europe Antisense and RNAi Therapeutics SWOT Analysis
5.6 China Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.6.1 China Antisense and RNAi Therapeutics Market Under COVID-19
5.6.2 China Antisense and RNAi Therapeutics SWOT Analysis
5.7 Japan Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.7.1 Japan Antisense and RNAi Therapeutics Market Under COVID-19
5.7.2 Japan Antisense and RNAi Therapeutics SWOT Analysis
5.8 Middle East and Africa Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.8.1 Middle East and Africa Antisense and RNAi Therapeutics Market Under COVID-19
5.8.2 Middle East and Africa Antisense and RNAi Therapeutics SWOT Analysis
5.9 India Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.9.1 India Antisense and RNAi Therapeutics Market Under COVID-19
5.9.2 India Antisense and RNAi Therapeutics SWOT Analysis
5.10 South America Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.10.1 South America Antisense and RNAi Therapeutics Market Under COVID-19
5.10.2 South America Antisense and RNAi Therapeutics SWOT Analysis
5.11 South Korea Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.11.1 South Korea Antisense and RNAi Therapeutics Market Under COVID-19
5.11.2 South Korea Antisense and RNAi Therapeutics SWOT Analysis
5.12 Southeast Asia Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
5.12.1 Southeast Asia Antisense and RNAi Therapeutics Market Under COVID-19
5.12.2 Southeast Asia Antisense and RNAi Therapeutics SWOT Analysis

6 Global Antisense and RNAi Therapeutics Production by Top Regions (2016-2021)
6.1 Global Antisense and RNAi Therapeutics Production by Top Regions (2016-2021)
6.2 North America Antisense and RNAi Therapeutics Production and Growth Rate
6.3 Europe Antisense and RNAi Therapeutics Production and Growth Rate
6.4 China Antisense and RNAi Therapeutics Production and Growth Rate
6.5 Japan Antisense and RNAi Therapeutics Production and Growth Rate
6.6 India Antisense and RNAi Therapeutics Production and Growth Rate

7 Global Antisense and RNAi Therapeutics Consumption by Regions (2016-2021)
7.1 Global Antisense and RNAi Therapeutics Consumption by Regions (2016-2021)
7.2 North America Antisense and RNAi Therapeutics Consumption and Growth Rate
7.3 Europe Antisense and RNAi Therapeutics Consumption and Growth Rate
7.4 China Antisense and RNAi Therapeutics Consumption and Growth Rate
7.5 Japan Antisense and RNAi Therapeutics Consumption and Growth Rate
7.6 Middle East & Africa Antisense and RNAi Therapeutics Consumption and Growth Rate
7.7 India Antisense and RNAi Therapeutics Consumption and Growth Rate
7.8 South America Antisense and RNAi Therapeutics Consumption and Growth Rate
7.9 South Korea Antisense and RNAi Therapeutics Consumption and Growth Rate
7.10 Southeast Asia Antisense and RNAi Therapeutics Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Alnylam Pharmaceuticals Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Antisense and RNAi Therapeutics Product Profiles, Application and Specification
8.2.3 Alnylam Pharmaceuticals Sales, Revenue, Price, Gross Margin 2016-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 GSK Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Antisense and RNAi Therapeutics Product Profiles, Application and Specification
8.3.3 GSK Sales, Revenue, Price, Gross Margin 2016-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Sanofi-Genzyme Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Antisense and RNAi Therapeutics Product Profiles, Application and Specification
8.4.3 Sanofi-Genzyme Sales, Revenue, Price, Gross Margin 2016-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Marina Biosciences Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Antisense and RNAi Therapeutics Product Profiles, Application and Specification
8.5.3 Marina Biosciences Sales, Revenue, Price, Gross Margin 2016-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Benitec Biopharma Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Antisense and RNAi Therapeutics Product Profiles, Application and Specification
8.6.3 Benitec Biopharma Sales, Revenue, Price, Gross Margin 2016-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Antisense and RNAi Therapeutics Market Analysis and Forecast by Type and Application
9.1 Global Antisense and RNAi Therapeutics Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 RNA Interference Market Revenue and Volume Forecast (2021-2026)
9.1.2 Antisense RNA Market Revenue and Volume Forecast (2021-2026)
9.2 Global Antisense and RNAi Therapeutics Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Oncology Market Revenue and Volume Forecast (2021-2026)
9.2.2 Cardiovascular Diseases (CVDs) Market Revenue and Volume Forecast (2021-2026)
9.2.3 Respiratory Disorders Market Revenue and Volume Forecast (2021-2026)
9.2.4 Renal Diseases Market Revenue and Volume Forecast (2021-2026)
9.2.5 Neurodegenerative Disorders Market Revenue and Volume Forecast (2021-2026)
9.2.6 Genetic Disorders Market Revenue and Volume Forecast (2021-2026)
9.2.7 Infectious Diseases Market Revenue and Volume Forecast (2021-2026)
9.2.8 Other Market Revenue and Volume Forecast (2021-2026)

10 Antisense and RNAi Therapeutics Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Antisense and RNAi Therapeutics Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?
List of Tables and Figures
Figure Product Picture of Antisense and RNAi Therapeutics
Table Product Specification of Antisense and RNAi Therapeutics
Figure Market Concentration Ratio and Market Maturity Analysis of Antisense and RNAi Therapeutics
Figure Global Antisense and RNAi Therapeutics Revenue ($) and Growth Rate from 2016-2026
Table Different Types of Antisense and RNAi Therapeutics
Table Global Antisense and RNAi Therapeutics Market Size Growth Rate by Type (2020-2026)
Figure Global Antisense and RNAi Therapeutics Revenue ($) Segment by Type from 2016-2021
Figure Global Antisense and RNAi Therapeutics Market Share by Types in 2020
Figure Antisense and RNAi Therapeutics RNA Interference Picture
Figure Antisense and RNAi Therapeutics Antisense RNA Picture
Table Different Applications of Antisense and RNAi Therapeutics
Table Global Antisense and RNAi Therapeutics Market Size Growth Rate by Applications (2020-2026)
Figure Global Antisense and RNAi Therapeutics Revenue ($) Segment by Applications from 2016-2021
Figure Global Antisense and RNAi Therapeutics Market Share by Applications in 2020
Figure Oncology Picture
Figure Cardiovascular Diseases (CVDs) Picture
Figure Respiratory Disorders Picture
Figure Renal Diseases Picture
Figure Neurodegenerative Disorders Picture
Figure Genetic Disorders Picture
Figure Infectious Diseases Picture
Figure Other Picture
Table Research Regions of Antisense and RNAi Therapeutics
Table Global Antisense and RNAi Therapeutics Market Size Growth Rate by Region (2020-2026)
Figure Global Antisense and RNAi Therapeutics Market Share by Regions in 2020
Figure North America Antisense and RNAi Therapeutics Revenue ($) and Growth Rate (2016-2021)
Figure Europe Antisense and RNAi Therapeutics Revenue ($) and Growth Rate (2016-2021)
Figure China Antisense and RNAi Therapeutics Revenue ($) and Growth Rate (2016-2021)
Figure Japan Antisense and RNAi Therapeutics Revenue ($) and Growth Rate (2016-2021)
Figure Middle East and Africa Antisense and RNAi Therapeutics Revenue ($) and Growth Rate (2016-2021)
Figure India Antisense and RNAi Therapeutics Revenue ($) and Growth Rate (2016-2021)
Figure South America Antisense and RNAi Therapeutics Revenue ($) and Growth Rate (2016-2021)
Figure South Korea Antisense and RNAi Therapeutics Revenue ($) and Growth Rate (2016-2021)
Figure Southeast Asia Antisense and RNAi Therapeutics Revenue ($) and Growth Rate (2016-2021)
Table SWOT Analysis
Table Market Challenges
Table Market Restraints
Table Industry News
Table Industry Policies
Table Mergers & Acquisitions, Expansion Plans
Table Influence of COVID-19 Outbreak on Antisense and RNAi Therapeutics Industry Development
Figure Industry Chain Analysis of Antisense and RNAi Therapeutics
Table Major Players Manufacturing Base of Antisense and RNAi Therapeutics in 2020
Table Major Players Market Distribution in 2020
Figure Production Process of Antisense and RNAi Therapeutics
Figure Manufacturing Cost Structure of Antisense and RNAi Therapeutics
Figure Channel Status of Antisense and RNAi Therapeutics
Table Major Distributors of Antisense and RNAi Therapeutics with Contact Information
Table Global Antisense and RNAi Therapeutics Revenue ($) by Type (2016-2021)
Table Global Antisense and RNAi Therapeutics Revenue Share by Type (2016-2021)
Figure Global Antisense and RNAi Therapeutics Revenue Share by Type (2016-2021)
Table Global Antisense and RNAi Therapeutics Production by Type (2016-2021)
Table Global Antisense and RNAi Therapeutics Production Share by Type (2016-2021)
Figure Global Antisense and RNAi Therapeutics Production Share by Type (2016-2021)
Figure Global Antisense and RNAi Therapeutics Revenue ($) and Growth Rate of RNA Interference
Figure Global Antisense and RNAi Therapeutics Revenue ($) and Growth Rate of Antisense RNA
Figure Global Antisense and RNAi Therapeutics Price by Type (2016-2021)
Figure Downstream Market Overview
Table Global Antisense and RNAi Therapeutics Consumption by Application (2016-2021)
Table Global Antisense and RNAi Therapeutics Consumption Market Share by Application (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption Market Share by Application (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Oncology (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Cardiovascular Diseases (CVDs) (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Respiratory Disorders (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Renal Diseases (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Neurodegenerative Disorders (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Genetic Disorders (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Infectious Diseases (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption and Growth Rate of Other (2016-2021)
Table Global Antisense and RNAi Therapeutics Revenue ($) by Region (2016-2021)
Table Global Antisense and RNAi Therapeutics Revenue Market Share by Region (2016-2021)
Figure Global Antisense and RNAi Therapeutics Revenue Market Share by Region (2016-2021)
Table Global Antisense and RNAi Therapeutics Consumption by Region (2016-2021)
Table Global Antisense and RNAi Therapeutics Consumption Market Share by Region (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption Market Share by Region (2016-2021)
Table Global Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table North America Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table North America Antisense and RNAi Therapeutics SWOT Analysis
Table Europe Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table Europe Antisense and RNAi Therapeutics SWOT Analysis
Table China Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table China Antisense and RNAi Therapeutics SWOT Analysis
Table Japan Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table Japan Antisense and RNAi Therapeutics SWOT Analysis
Table Middle East and Africa Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table Middle East and Africa Antisense and RNAi Therapeutics SWOT Analysis
Table India Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table India Antisense and RNAi Therapeutics SWOT Analysis
Table South America Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table South America Antisense and RNAi Therapeutics SWOT Analysis
Table South Korea Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table South Korea Antisense and RNAi Therapeutics SWOT Analysis
Table Southeast Asia Antisense and RNAi Therapeutics Consumption, Revenue, Price and Gross Margin (2016-2021)
Table Southeast Asia Antisense and RNAi Therapeutics SWOT Analysis
Table Global Antisense and RNAi Therapeutics Production by Top Regions (2016-2021)
Figure Global Antisense and RNAi Therapeutics Production Share by Top Regions (2016-2021)
Figure North America Antisense and RNAi Therapeutics Production and Growth Rate Analysis (2016-2021)
Figure Europe Antisense and RNAi Therapeutics Production and Growth Rate Analysis (2016-2021)
Figure China Antisense and RNAi Therapeutics Production and Growth Rate Analysis (2016-2021)
Figure Japan Antisense and RNAi Therapeutics Production and Growth Rate Analysis (2016-2021)
Figure India Antisense and RNAi Therapeutics Production and Growth Rate Analysis (2016-2021)
Table Global Antisense and RNAi Therapeutics Consumption by Regions (2016-2021)
Figure Global Antisense and RNAi Therapeutics Consumption Share by Regions (2016-2021)
Figure North America Antisense and RNAi Therapeutics Consumption and Growth Rate Analysis (2016-2021)
Figure Europe Antisense and RNAi Therapeutics Consumption and Growth Rate Analysis (2016-2021)
Figure China Antisense and RNAi Therapeutics Consumption and Growth Rate Analysis (2016-2021)
Figure Japan Antisense and RNAi Therapeutics Consumption and Growth Rate Analysis (2016-2021)
Figure Middle East & Africa Antisense and RNAi Therapeutics Consumption and Growth Rate Analysis (2016-2021)
Figure India Antisense and RNAi Therapeutics Consumption and Growth Rate Analysis (2016-2021)
Figure South America Antisense and RNAi Therapeutics Consumption and Growth Rate Analysis (2016-2021)
Figure South Korea Antisense and RNAi Therapeutics Consumption and Growth Rate Analysis (2016-2021)
Figure Southeast Asia Antisense and RNAi Therapeutics Consumption and Growth Rate Analysis (2016-2021)
Figure Top 3 Market Share of Antisense and RNAi Therapeutics Companies in 2020
Figure Top 6 Market Share of Antisense and RNAi Therapeutics Companies in 2020
Table Major Players Revenue ($) Share (2016-2021)
Table Company Profiles
Table Product Profiles, Application and Specification
Table Alnylam Pharmaceuticals Company Profiles
Table Alnylam Pharmaceuticals Sales, Revenue, Price, Gross Margin 2016-2021
Figure Alnylam Pharmaceuticals Sales and Growth Rate
Figure Alnylam Pharmaceuticals Revenue ($) Market Share 2016-2021
Table GSK Company Profiles
Table GSK Sales, Revenue, Price, Gross Margin 2016-2021
Figure GSK Sales and Growth Rate
Figure GSK Revenue ($) Market Share 2016-2021
Table Sanofi-Genzyme Company Profiles
Table Sanofi-Genzyme Sales, Revenue, Price, Gross Margin 2016-2021
Figure Sanofi-Genzyme Sales and Growth Rate
Figure Sanofi-Genzyme Revenue ($) Market Share 2016-2021
Table Marina Biosciences Company Profiles
Table Marina Biosciences Sales, Revenue, Price, Gross Margin 2016-2021
Figure Marina Biosciences Sales and Growth Rate
Figure Marina Biosciences Revenue ($) Market Share 2016-2021
Table Benitec Biopharma Company Profiles
Table Benitec Biopharma Sales, Revenue, Price, Gross Margin 2016-2021
Figure Benitec Biopharma Sales and Growth Rate
Figure Benitec Biopharma Revenue ($) Market Share 2016-2021
Table Global Antisense and RNAi Therapeutics Market Revenue ($) Forecast, by Type
Table Global Antisense and RNAi Therapeutics Market Volume Forecast, by Type
Figure Global Antisense and RNAi Therapeutics Market Revenue ($) and Growth Rate Forecast of RNA Interference (2021-2026)
Figure Global Antisense and RNAi Therapeutics Market Volume and Growth Rate Forecast of RNA Interference (2021-2026)
Figure Global Antisense and RNAi Therapeutics Market Revenue ($) and Growth Rate Forecast of Antisense RNA (2021-2026)
Figure Global Antisense and RNAi Therapeutics Market Volume and Growth Rate Forecast of Antisense RNA (2021-2026)
Table Global Market Revenue ($) Forecast by Application (2021-2026)
Table Global Market Volume Forecast by Application (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Oncology (2021-2026)
Figure Market Volume and Growth Rate Forecast of Oncology (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Cardiovascular Diseases (CVDs) (2021-2026)
Figure Market Volume and Growth Rate Forecast of Cardiovascular Diseases (CVDs) (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Respiratory Disorders (2021-2026)
Figure Market Volume and Growth Rate Forecast of Respiratory Disorders (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Renal Diseases (2021-2026)
Figure Market Volume and Growth Rate Forecast of Renal Diseases (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Neurodegenerative Disorders (2021-2026)
Figure Market Volume and Growth Rate Forecast of Neurodegenerative Disorders (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Genetic Disorders (2021-2026)
Figure Market Volume and Growth Rate Forecast of Genetic Disorders (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Infectious Diseases (2021-2026)
Figure Market Volume and Growth Rate Forecast of Infectious Diseases (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Other (2021-2026)
Figure Market Volume and Growth Rate Forecast of Other (2021-2026)
Figure North America Market Supply and Growth Rate Forecast (2021-2026)
Figure North America Demand and Growth Rate Forecast (2021-2026)
Figure Europe Market Supply and Growth Rate Forecast (2021-2026)
Figure Europe Demand and Growth Rate Forecast (2021-2026)
Figure China Market Supply and Growth Rate Forecast (2021-2026)
Figure China Demand and Growth Rate Forecast (2021-2026)
Figure Japan Market Supply and Growth Rate Forecast (2021-2026)
Figure Japan Demand and Growth Rate Forecast (2021-2026)
Figure Middle East and Africa Market Supply and Growth Rate Forecast (2021-2026)
Figure Middle East and Africa Demand and Growth Rate Forecast (2021-2026)
Figure India Market Supply and Growth Rate Forecast (2021-2026)
Figure India Demand and Growth Rate Forecast (2021-2026)
Figure South America Market Supply and Growth Rate Forecast (2021-2026)
Figure South America Demand and Growth Rate Forecast (2021-2026)
Figure South Korea Market Supply and Growth Rate Forecast (2021-2026)
Figure South Korea Demand and Growth Rate Forecast (2021-2026)
Figure Southeast Asia Market Supply and Growth Rate Forecast (2021-2026)
Figure Southeast Asia Demand and Growth Rate Forecast (2021-2026)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
  • Global Targeted RNA Sequencing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......
  • Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......
  • Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94
    According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......
  • Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Market Status and Outlook 2023-2028
    Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106
    RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104
    Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs